Newsfeeds Archive - Page 2 of 3

1 minute read

Why Are Draganfly Shares Moving Lower Wednesday?

March 29, 10:15 AM

Shares of drone solutions and systems developer Draganfly Inc (NASDAQ: DPRO) are falling in early trading Wednesday after the company announced a proposed underwritten public offering to secure growth capital.

DPRO

1 minute read

Draganfly Announces Pricing Of $8.M Underwritten Public Offering Of 8M Shares Of Common Stock At A Price Of $1/Share To Secure Growth Capital

By Happy Mohamed

March 29, 8:56 AM

Draganfly Inc. (NASDAQ:DPRO) (CSE:DPRO) (FSE: 3U8) ("Draganfly" or the "Company"), a drone solutions and systems developer, today announced the pricing of a firm commitment underwritten public

CSE:DPRO

2 minute read

Why Shift Technologies Shares Are Trading Lower By 15%; Here Are 20 Stocks Moving Premarket

By Lisa Levin

March 29, 8:05 AM

Gainers LogicMark, Inc. (NASDAQ: LGMK) shares rose 36.7% to $0.1914 in pre-market trading after the company reported strong revenue and margin growth for the year ended 2022.

ARCT

3 minute read

Why Alibaba Shares Are Trading Higher By Over 8%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session

By Lisa Levin

March 28, 1:04 PM

Gainers

ALLR

2 minute read

AMD To Rally Over 26%? Here Are 10 Other Analyst Forecasts For Wednesday

By Lisa Levin

February 1, 9:10 AM

Credit Suisse boosted the price target for Mondelez International, Inc. (NASDAQ: MDLZ) from $70 to $76. Credit Suisse analyst Robert Moskow maintained an Outperform rating. Mondelez shares rose 1.8% to $66.61 in pre-market trading.

AMD

1 minute read

HC Wainwright & Co. Maintains Buy on Draganfly, Raises Price Target to $3.5

By Benzinga Newsdesk

February 1, 7:42 AM

HC Wainwright & Co. analyst Scott Buck maintains Draganfly (NASDAQ:DPRO) with a Buy and raises the price target from $2 to $3.5.

DPRO

3 minute read

Why Baudax Bio Shares Are Trading Higher By 60%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session

By Lisa Levin

January 24, 2:11 PM

Gainers Baudax Bio, Inc. (NASDAQ: BXRX) shares surged 59.7% to $5.03 after the company announced the outcome of its first interim analysis in a Phase II trial of BX1000 for neuromuscular blockade in patients undergoing elective surgery.

AHPI

1 minute read

News

5 Value Stocks In The Industrials Sector

By Benzinga Insights

January 11, 10:40 AM

Understanding Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are…

CAAP

1 minute read

General

Draganfly Launches New Flight Facility For Land Mine And Anomaly Detection Protocols

By Bill Haddad

December 7, 8:38 AM

Draganfly Inc. (NASDAQ:DPRO) (CSE:DPRO) (FSE: 3U8) ("Draganfly" or the "Company"), an award-winning, industry-leading drone solutions and systems developer, is pleased to announce the launch of the

CSE:DPRO